These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 25176504)

  • 1. Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies.
    Ten Dam L; van der Kooi AJ; Rövekamp F; Linssen WH; de Visser M
    Neuromuscul Disord; 2014 Dec; 24(12):1097-102. PubMed ID: 25176504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANO5 mutations in the Dutch limb girdle muscular dystrophy population.
    van der Kooi AJ; Ten Dam L; Frankhuizen WS; Straathof CS; van Doorn PA; de Visser M; Ginjaar IB
    Neuromuscul Disord; 2013 Jun; 23(6):456-60. PubMed ID: 23607914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies.
    Bolduc V; Marlow G; Boycott KM; Saleki K; Inoue H; Kroon J; Itakura M; Robitaille Y; Parent L; Baas F; Mizuta K; Kamata N; Richard I; Linssen WH; Mahjneh I; de Visser M; Bashir R; Brais B
    Am J Hum Genet; 2010 Feb; 86(2):213-21. PubMed ID: 20096397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy.
    Schessl J; Kress W; Schoser B
    Muscle Nerve; 2012 May; 45(5):740-2. PubMed ID: 22499103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle MRI findings in limb girdle muscular dystrophy type 2L.
    Sarkozy A; Deschauer M; Carlier RY; Schrank B; Seeger J; Walter MC; Schoser B; Reilich P; Leturq F; Radunovic A; Behin A; Laforet P; Eymard B; Schreiber H; Hicks D; Vaidya SS; Gläser D; Carlier PG; Bushby K; Lochmüller H; Straub V
    Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S122-9. PubMed ID: 22980763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anoctamin 5 Knockout Mouse Model Recapitulates LGMD2L Muscle Pathology and Offers Insight Into in vivo Functional Deficits.
    Thiruvengadam G; Sreetama SC; Charton K; Hogarth M; Novak JS; Suel-Petat L; Chandra G; Allard B; Richard I; Jaiswal JK
    J Neuromuscul Dis; 2021; 8(s2):S243-S255. PubMed ID: 34633328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective membrane fusion and repair in Anoctamin5-deficient muscular dystrophy.
    Griffin DA; Johnson RW; Whitlock JM; Pozsgai ER; Heller KN; Grose WE; Arnold WD; Sahenk Z; Hartzell HC; Rodino-Klapac LR
    Hum Mol Genet; 2016 May; 25(10):1900-1911. PubMed ID: 26911675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5.
    Penttilä S; Palmio J; Suominen T; Raheem O; Evilä A; Muelas Gomez N; Tasca G; Waddell LB; Clarke NF; Barboi A; Hackman P; Udd B
    Neurology; 2012 Mar; 78(12):897-903. PubMed ID: 22402862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.
    Kesper K; Kornblum C; Reimann J; Lutterbey G; Schröder R; Wattjes MP
    Acta Neurol Scand; 2009 Aug; 120(2):111-8. PubMed ID: 19154541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.
    Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I
    Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-onset limb-girdle muscular dystrophy-2L in a female athlete.
    Blackburn PR; Selcen D; Jackson JL; Guthrie KJ; Cousin MA; Boczek NJ; Clift KE; Klee EW; Dimberg EL; Atwal PS
    Muscle Nerve; 2017 May; 55(5):E19-E21. PubMed ID: 27862037
    [No Abstract]   [Full Text] [Related]  

  • 12. A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy.
    Hicks D; Sarkozy A; Muelas N; Köehler K; Huebner A; Hudson G; Chinnery PF; Barresi R; Eagle M; Polvikoski T; Bailey G; Miller J; Radunovic A; Hughes PJ; Roberts R; Krause S; Walter MC; Laval SH; Straub V; Lochmüller H; Bushby K
    Brain; 2011 Jan; 134(Pt 1):171-182. PubMed ID: 21186264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First familial limb-girdle muscular dystrophy 2L in China: Clinical, imaging, pathological, and genetic features.
    Hu B; Xiong L; Zhou Y; Lu X; Xiong Q; Liu Q; Qi X; Ding W
    Medicine (Baltimore); 2018 Sep; 97(38):e12506. PubMed ID: 30235762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up study on patients with Miyoshi phenotype of distal muscular dystrophy.
    Linssen WH; de Voogt WG; Krahn M; Bernard R; Levy N; Wokke JH; Ginjaar HB; de Visser M
    Eur J Neurol; 2013 Jun; 20(6):968-74. PubMed ID: 23530687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutations in the Anoctamin 5 gene (ANO5) associated with limb-girdle muscular dystrophy 2L.
    Little AA; McKeever PE; Gruis KL
    Muscle Nerve; 2013 Feb; 47(2):287-91. PubMed ID: 23169617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.
    Diers A; Carl M; Stoltenburg-Didinger G; Vorgerd M; Spuler S
    Neuromuscul Disord; 2007 Feb; 17(2):157-62. PubMed ID: 17129727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated semitendinosus involvement in the initial stages of limb-girdle muscular dystrophy 2L.
    Tasca G; Evilä A; Pane M; Monforte M; Graziano A; Hackman P; Mercuri E; Udd B
    Neuromuscul Disord; 2014 Dec; 24(12):1118-9. PubMed ID: 25149668
    [No Abstract]   [Full Text] [Related]  

  • 18. Miyoshi-like distal myopathy with mutations in anoctamin 5 gene.
    Bouquet F; Cossée M; Béhin A; Deburgrave N; Romero N; Leturcq F; Eymard B
    Rev Neurol (Paris); 2012 Feb; 168(2):135-41. PubMed ID: 22336395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic Spectrum of Myopathies with Recessive Anoctamin-5 Mutations.
    Vázquez J; Lefeuvre C; Escobar RE; Luna Angulo AB; Miranda Duarte A; Delia Hernandez A; Brisset M; Carlier RY; Leturcq F; Durand-Canard MC; Nicolas G; Laforet P; Malfatti E
    J Neuromuscul Dis; 2020; 7(4):443-451. PubMed ID: 32925086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
    Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.